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Summary
In the final stages of ovarian follicular development,
the mouse oocyte remains arrested in the first meiotic
prophase, and cAMP-stimulated PKA plays an essen-
tial role in this arrest. After the LH surge, a decrease
in cAMP and PKA activity in the oocyte initiates an
irreversible maturation process that culminates in a
second arrest at metaphase II prior to fertilization [1].
A-kinase anchoring proteins (AKAPs) mediate the
intracellular localization of PKA and control the spec-
ificity and kinetics of substrate phosphorylation [2].
Several AKAPs have been identified in oocytes includ-
ing one at 140 kDa [3, 4] that we now identify as a prod-
uct of the Akap1 gene. We show that PKA interaction
with AKAPs is essential for two sequential steps in
the maturation process: the initial maintenance of
meiotic arrest and the subsequent irreversible prog-
ression to the polar body extruded stage. A peptide in-
hibitor (HT31) that disrupts AKAP/PKA interactions
stimulates oocyte maturation in the continued pres-
ence of high cAMP. However, during the early minutes
of maturation, type II PKA moves from cytoplasmic
sites to the mitochondria, where it associates with
AKAP1, and this is shown to be essential for matura-
tion to continue irreversibly.
Results and Discussion
Generation of AKAP1 Knockout Mice
The central exon2 of Akap1 encodes the majority of the
protein in all splice variants, and we replaced this exon
with a neomycin resistance cassette to create a com-
plete Akap1 knockout mouse (Figure 1). Western blot
analysis indicated that all variants of the AKAP1 protein
were absent in knockout tissues including the ovary
(Figure 1C). Previous work has reported that the pre-
dominant AKAP in rodent oocytes migrates at 140 kDa
on an RII overlay assay [3, 4]. By using a similar RII over-
lay assay, we showed that AKAP1 also migrated at 140
kDa and could be identified as the predominant AKAP
in the oocyte since it was absent in the knockout
(Figure 1D).
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and Associates with Mitochondria
Breeding studies revealed that AKAP1 knockout fe-
males had greatly reduced fertility, so we examined
the expression and localization of AKAP1 in the ovary.
AKAP1 was found primarily in the oocyte in various
stages of follicular development, including preantral
and antral follicles (Figure 1E). Immunocytochemical
studies of wild-type oocytes showed mitochondrial lo-
calization of AKAP1 and absence of AKAP1 in the cumu-
lus granulosa cells (Figure 1F). Furthermore, real-time
RT-PCR indicated that N0, the mitochondrial splice var-
iant of AKAP1, is the predominant splice variant in the
oocyte, whereas the N1 endoplasmic reticulum splice
variant is absent (data not shown).
AKAP1 Knockout Females Are Subfertile
Although AKAP1 knockout males were fertile, AKAP1
knockout females were subfertile or infertile, whereas
the AKAP1 heterozygous females had normal fertility.
When AKAP1 heterozygous females were mated to
C57BL/6J male mice, the expected number of litters
per female per month were produced (0.86), with 7.7 6
1.2 pups/litter. In contrast, AKAP1 knockout females
gave birth at a rate of 0.26 litters/female/month and a lit-
ter size of 2.26 0.8 pups/litter. This reduced fertility was
present regardless of the background strain of the fe-
males (129X1/SvJ versus C57BL6/J) and was indepen-
dent of the AKAP1 genotype of the males to which
they were mated (see Figure S1 in the Supplemental
Data available with this article online).
Ovarian histology was normal in prepubertal supero-
vulated (3- to 4-week-old) and mature nonsuperovulated
(12-week-old) knockout females (data not shown), and
serum LH and FSH levels were also unchanged, indicat-
ing that the effect of AKAP1 deficiency on female fertility
was not hormonally related. Superovulation resulted in
a similar number of eggs ovulated in both knockout
and control females (Figure S1), although many of the
eggs in knockout females appeared to be immature or
degenerated (Figure 2A).
Ovulated Oocytes from AKAP1 Knockout Females
Failed to Resume Meiosis
After superovulation with gonadotropins and in vivo
mating, we found that most oocytes from knockout fe-
males were either degenerated or arrested in GV stage
and had not extruded a polar body, an indication that
the oocytes had not progressed to metaphase II and fer-
tilization competence. However, when these embryos
were cultured in vitro, those that had extruded a polar
body were able to become two-cell embryos and sub-
sequently morula (Figure 2A).
AKAP1 Knockout Oocytes Harvested from the Ovary
Are Defective in Maturation In Vitro
Oocytes were harvested from the ovaries of PMSG-
primed females, and cumulus granulosa cells were re-
moved. After 3 hr in culture, 79% of germinal vesicle
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322Figure 1. Generation of AKAP1 Knockout
Mice
(A) Targeting of the wild-type allele (top) by
homologous recombination led to disruption
of exon 2 of AKAP1 and insertion of the neo-
mycin-resistant cassette (bottom). B, BamHI;
BsrG, BsrGI; E, EcoRI; P, Pac.
(B) Genomic Southern blot of ES cells trans-
fected with the mutant construct was con-
ducted by digesting DNA with BamH1. The
wild-type band migrates at 15 kb and the
knockout band at 10 kb.
(C) Western blot analyses of protein samples
of ovaries from AKAP1 wild-type and knock-
out mice indicated that the 140 kDa isoform
is absent in knockout mice.
(D) RII overlay on oocytes indicated that
AKAP1 is a predominant AKAP in the oocyte.
Protein from 100 GV-stage oocytes from ei-
ther wild-type or knockout females was sep-
arated on an SDS-PAGE gel. The protein was
transferred to a nitrocellulose membrane and
the membrane was incubated in RIIb protein,
followed by incubation with an RIIb antibody.
The red arrow indicates AKAP1.
(E) Confocal micrograph images showed im-
munostaining for aAKAP1 (green) in ovarian
sections. Nuclei were stained with DAPI
(blue). AKAP1 was predominantly expressed
in the oocyte in different stages of follicular
development. Preantral and preovulatory fol-
licles are shown. The experiment was con-
ducted three times and representative im-
ages are shown (2503 magnification). gc,
granulosa cells.
(F) Within the oocyte (GV stage), AKAP1
(green) showed a punctate distribution that
colocalized to the mitochondria (red). Nuclei
are stained with ToPro3 (blue). AKAP1 was
excluded from cumulus granulosa cells (gc),
as shown in the middle panels.(GV)-stage oocytes from heterozygous females re-
sumed meiosis and underwent maturation, as indicated
by germinal vesicle breakdown (GVBD). However, only
50% of oocytes from knockout females underwent
GVBD (Figure 2B). Oocytes from knockout females
that matured in vitro showed activation of maturation
promoting factor (MPF) and MAP kinase (MAPK), as
did wild-type (data not shown). Interestingly, the matu-
ration of knockout oocytes could be rescued by the
addition of 100 mM Rp-adenosine 3,5-cyclic monophos-
phorothioate (Rp-cAMPS), an inhibitor of PKA (Fig-
ure 2B). Even more strikingly, 83% of knockout oocytes
incubated in 100 mM Rp-cAMPS for 2 hr and then
washed were rescued to polar body stage 20 hr later
(Figure 2C). In contrast, only 33% of oocytes from
knockout females extruded polar bodies in the absence
of Rp-cAMPS treatment. Based on this result, we hy-
pothesized that PKA is inappropriately active in the
knockout oocytes. The defect seen in oocyte maturation
when triggered in vitro in granulosa-free oocytes is less
dramatic than that observed in vivo when oocytes ma-
ture in the presence of the cumulus granulosa cells. This
is consistent with the possibility that knockout oocytes
have become more sensitive to cAMP-activated arrest
because of a change in PKA localization and thatgranulosa cells are still providing signals to the oocyte
that partially maintain levels of cAMP even during LH-in-
duced ovulation.
AKAP1 Knockout Oocytes Are More Sensitive
to cAMP
Either the total activity or subcellular localization of PKA
might be affected in the oocyte as a result of deletion of
AKAP1. Total cAMP levels were unchanged in knockout
GV-stage oocytes (data not shown), and the levels of
PKA subunits and the activity of PKA was also normal
(Figure S2). However, knockout oocytes were more sen-
sitive to inhibition of GVBD by the PDE inhibitor, 3-isobu-
tyl-1-methylxanthine (IBMX) (Figure 2D). To confirm that
AKAP1 knockout oocytes are more sensitive to cAMP
and not merely PDE inhibition, GVBD experiments
were conducted with oocytes incubated in increasing
concentrations of the cAMP analogs N6,2-O-Dibutyryla-
denosine cAMP (db-cAMP) and 6-Dichloro-1-b- D-ribo-
furanosylbenzimidazole 30,50-cyclic monophosphoro-
thioate, Sp-isomer (Sp-5,6-DCl-cBIMPS). Oocytes from
AKAP1 knockout females were more sensitive to the in-
hibitory effects of db-cAMP and Sp-5,6-DCl-cBIMPS on
GVBD than oocytes from wild-type females (data not
shown).
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323Figure 2. Embryos from AKAP1 Knockout
Females Failed to Mature and Were More
Sensitive to cAMP
(A) Female AKAP1 knockout or heterozygous
mice (22- to 26-days-old) were injected with
PMSG, followed by hCG 48 hr later. Imme-
diately after hCG injection, females were
housed individually with wild-type males. Em-
bryos were harvested from the oviduct of the
females 24 hr later. The embryos were placed
in HTF (Irvine Scientific) media supplemented
with 0.25 mM EDTA for 72 hr. Embryonic stage
was monitored during this time. n = 135 em-
bryos from heterozygous females, n = 97 em-
bryos from knockout females.
(B) In vitro GVBD was decreased in oocytes
from knockout females. Denuded oocytes
from heterozygous and knockout females
were collected from ovaries 48 hr after
PMSG injection. These oocytes were then as-
sessed for GVBD (meiotic resumption) 3 hr
later. Oocytes with a clear nuclear membrane
(GV) and nucleoli were classified as being at
the GV stage, while those without a visible
nuclear structure were classified as GVBD
stage. An inhibitor of PKA, Rp-cAMPS
(100 mM), reversed the defect in GVBD in
knockout oocytes but had no effect in oocytes
from heterozygous females. Results are ex-
pressed as mean 6 SEM for seven experi-
ments (no treatment) and four experiments
(Rp-cAMPS). *p < 0.05 by a repeated mea-
sures ANOVA with a Newman Kuels post test.
(C) In vitro polar body formation was restored
to wild-type levels in AKAP1 knockout oo-
cytes treated with 100 mM Rp-cAMPS. De-
nuded oocytes from wild-type and knockout
females were collected from ovaries 48 hr af-
ter PMSG injection and incubated at 37ºC
with or without Rp-cAMPS (100 mM). After 2
hr of incubation, the Rp-cAMPS was washed
out of the media, the oocytes were returned
to the incubator, and polar body formation
was assessed 18 hr later. Results are ex-
pressed as mean 6 SEM for six experiments
(knockout) and three experiments (wild-type).
*p < 0.001 by a one-way ANOVA with a
Newman Kuels post test.
(D) Oocytes from AKAP1 knockout females
were more sensitive to the inhibitory effects
of IBMX on GVBD. Oocytes incubated with in-
creasing concentrations of the IBMX were
scored for GVBD 3 hr after treatment. Values
are expressed as mean6 SEM for four exper-
iments.
(E) RI-specific cAMP analogs synergistically inhibit GVBD in oocytes from AKAP1 wild-type mice. Denuded oocytes were incubated with 40 mM of
8cpt-cAMP and increasing concentrations of 8-AHA-cAMP to stimulate RI. Oocytes were scored for GVBD 3 hr after treatment. Values are ex-
pressed as mean 6 SEM for three experiments.
(F) RII-specific cAMP analogs synergistically inhibit GVBD in oocytes from AKAP1 wild-type mice. Denuded oocytes were incubated with 40 mM
of 8cpt-cAMP and increasing concentrations of N6mb-cAMP to stimulate RII. Oocytes were scored for GVBD 3 hr after treatment. Values are
expressed as mean 6 SEM for three experiments.The RIIa Subtype of PKA Is a Major Regulator
of Meiotic Arrest in Wild-Type Oocytes
Although it was previously thought that RIIa was not ex-
pressed in rodent oocytes, more recent work has docu-
mented the presence of both RIa and RIIa [3, 4], although
it has been suggested that RIa-PKA is the major subtype
responsible for maintaining meiotic arrest [5, 6]. To re-
examine the relative contribution of RIa and RIIa con-
taining PKA to meiotic arrest, we measured GVBD in re-
sponse to stimulation of oocytes with cAMP analogs thatpreferentially activate holoenzymes containing either
RIa or RIIa. We used cAMP analogs that differ in their rel-
ative affinities for the A and B cAMP binding sites on RIa
and RIIa, choosing analog combinations that act syner-
gistically on only one of the two isoforms, while activa-
tion of the other isoform is additive [7, 8].
GV-stage oocytes were obtained from PMSG-treated
wild-type ovaries, denuded, and incubated with increas-
ing concentrations of the subtype-specific analogs. In
AKAP1 wild-type oocytes, activation of RIIa (Figure 2F)
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Oocyte Maturation
(A) ICC was conducted on GV-stage oocytes
with primary antibodies to PKA RIIa (green),
Mitotracker (red), and ToPro (blue).
(B) ICC was conducted in MII-stage oocytes.
(C) ICC was conducted in wild-type oocytes
collected from ovarian follicles and incubated
for 1.5 or 6 hr, respectively. Primary anti-
bodies to RIIa (green) and Mitotracker (red)
were used. Oocytes were counterstained
with ToPro (blue). This experiment was con-
ducted three times, and representative im-
ages are shown.
(D) ICC was conducted in MII-stage wild-type
oocytes with primary antibodies to AKAP1
(green) or AKAP7g (green) and Mitotracker
(red) or RIIa (red). Oocytes were counter-
stained with ToPro (blue). These experiments
were conducted three times, and representa-
tive images are shown.gave a more synergistic inhibition of GVBD than seen
with RIa (Figure 2E), suggesting that RIIa PKA plays an
important role in maintaining meiotic arrest.
PKA Localization Is Unchanged in AKAP1 Knockout
GV-Stage Oocytes
We hypothesized that the increased sensitivity to cAMP
in knockout oocytes results from changes in PKA local-
ization. Subcellular fractionation of mitochondria from
wild-type GV-stage oocytes indicated that AKAP1 local-
ized completely to the mitochondrial compartment as
expected from immunocytochemistry (ICC). However,
RIIa was not associated with the mitochondrial com-
partment and was found in the 17,000 3 g supernatant
(Figure S4). Localization of the RIa, RIIa, and Ca sub-
units of PKA was further examined in GV-stage oocytes
by ICC. RIIa localization in knockout oocytes was indis-
tinguishable from that of wild-type oocytes (Figure 3A),
and in agreement with fractionation studies did not co-
localize with mitochondria. The other PKA subunits ex-
pressed in the oocyte (RIa, Ca) also did not colocalize
with mitochondria by ICC or direct fractionation studies
(data not shown). Unexpectedly, these data indicate that
PKA is unable to interact with AKAP1 at the mitochon-
drial membrane in GV-stage oocytes.
Dynamic Relocalization of RIIa-PKA to Mitochondria
Occurs prior to GVBD and Is Dependent on AKAP1
Other groups have demonstrated that PKA localization
changes as the oocyte resumes meiosis [3, 4]. We asked
whether any of these changes in PKA localization were
dependent on the presence of AKAP1. Metaphase II
(MII) stage oocytes were collected from the oviducts of
superovulated females. Although most knockout oo-
cytes do not mature to the MII stage, sufficient numbers
of MII knockout oocytes could be obtained for the ICCexperiments. Although RIIa did not associate with the
mitochondria in wild-type GV-stage oocytes, it colocal-
ized with mitochondria in wild-type MII oocytes but not
in knockout MII oocytes (Figure 3B). We also directly
demonstrated that RIIa colocalized with AKAP1 in wild-
type MII oocytes (Figure 3D). RIIa did not colocalize
with mitochondria in AKAP1 knockout oocytes that
reached the MII stage, but instead localized at the corti-
cal region of the oocyte (Figure 3B) in a pattern that was
similar to the localization of another AKAP, AKAP7g
(Figure 3D). The intracellular localization of mitochondria
and the movement of mitochondria during maturation
were the same in both wild-type and knockout oocytes
(Figure S3).
We examined whether the relocalization of RIIa to the
mitochondria occurred early or late in the maturation
process. GV-stage oocytes were isolated from the ova-
ries of wild-type mice, incubated for 1.5 to 6 hr, and as-
sessed for meiotic stage and type II PKA localization. As
shown in Figure 3C and Figure S4, RIIa begins to localize
to the mitochondria within 1.5 hr after maturation is initi-
ated and prior to the GVBD stage and remains localized
throughout the MI stage after GVBD (6 hr). After a 2 hr
maturation, subcellular fractionation of oocyte extracts
indicated that about 50% of the RIIa was now associ-
ated with the mitochondrial pellet and AKAP1 (Fig-
ure S4).
Localization Plays a Dual Role in the Process
of Oocyte Maturation
Our results suggest that anchoring of RIIa-PKA to
AKAP1 on mitochondria effectively prevents that holo-
enzyme from interfering with the maturation process
once it is initiated. Since other AKAPs are also present
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325Figure 4. Correct PKA Localization Is Re-
quired for Meiotic Resumption
(A) Oocytes microinjected with 0.1 mM HT31
or 0.1 mM HT31-P were incubated with or
without 0.2 mM IBMX and scored for GVBD
3 hr after treatment. Values are expressed
as mean 6 SEM for three experiments.
(B) Wild-type and knockout GV-stage oo-
cytes were treated with Rp-cAMPS (100 mM)
for 1 hr followed by a wash out. IBMX (0.2
mM) was then added, and GVBD was ob-
served 3 hr later. Values are expressed as
mean 6 SEM for three experiments.
(C) Model of AKAP function in the oocyte. In
the wild-type GV oocyte, the RIIa subunit of
PKA does not interact with AKAP1, but we hy-
pothesize that it is associated with an uniden-
tified AKAP, AKAPx. As the wild-type oocyte
begins to mature, RIIa translocates and binds
AKAP1 at the mitochondria. MPF, maturation
promoting factor, a complex of CDK1 and cy-
clin B; cdc25b, a dual specificity phospha-
tase shown to act on CDK1 to activate it;
wee1, a tyrosine kinase that phosphorylates
and inactivates CDK1. AKAP1 is shown asso-
ciated with mitochondria at all times.in the oocyte [3, 4, 9–11], we asked whether this was the
only role for PKA anchoring in oocyte maturation. A pep-
tide inhibitor of AKAP interactions with R subunits,
HT31, was injected into wild-type GV-stage oocytes
that were incubated in the presence of IBMX to maintain
them in an arrested state. Surprisingly, HT31 stimulated
oocyte maturation as measured by GVBD, overcoming
the IBMX-induced arrest; as a control, the inactive pro-
line-substituted HT31-P had no effect. HT31 was just
as effective at promoting maturation as PKI (data not
shown), a well-studied stimulator of frog and mouse oo-
cyte maturation [1, 12]. These data indicate that PKA lo-
calization to an AKAP other than AKAP1 is essential at
an early stage in order for cAMP to maintain the arrest
of oocytes in meiosis I prophase.
Previous work has shown that once the process of oo-
cyte maturation is initiated, it proceeds to completion in
an irreversible manner [13]. This implies that there issome type of molecular ‘‘switch’’ that initiates meiosis
and cannot be turned off easily once this process has be-
gun. We suggest that this switch might involve the relo-
calization of PKA within the oocyte during the early
stages of GVBD. To determine whether changes in PKA
localization can affect the reversibility of meiotic matura-
tion, we treated wild-type and knockout GV-stage
oocytes with the PKA inhibitor Rp-cAMPS for 1 hr. We
then removed the Rp-cAMPS and added IBMX to in-
crease cAMP levels. Wild-type oocytes had activated
their ‘‘meiotic switch’’ after 1 hr, and GVBD could not
be inhibited by the addition of IBMX. However, the res-
cue in GVBD that was observed in knockout oocytes
with Rp-cAMPS was partially reversed just by washing
out the Rp-cAMPS at 1 hr and completely reversed
when IBMX was added to elevate cAMP (Figure 4B).
Studies in vitro demonstrate that PKA activation
inhibits GVBD [14–16], and inhibitors of either cAMP
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19]. The maturation pathway in oocytes is controlled
by MPF, a complex of CDK1 and cyclin B. The CDK1
kinase is inhibited by phosphorylation at tyrosine 15
by Wee1, and this site as well as threonine 14 is de-
phosphorylated by the dual specificity phosphatase,
Cdc25b. Xenopus Cdc25 has been shown to be phos-
phorylated by PKA, and this phosphorylation may lead
to association of the phosphatase with 14-3-3 and in-
hibition of its activity [20]. Disruption of the mouse
Cdc25b gene demonstrates that this phosphatase is
an important activator of maturation, and in its absence,
oocytes remain arrested at prophase with low MPF ac-
tivity [21].
Our work reveals that the localization of PKA is also
an essential element of the decision of oocytes to com-
mit to the maturation program. In GV-stage oocytes,
the RIIa PKA holoenzyme localizes in a widely distrib-
uted punctate pattern throughout the cytoplasm. As
shown in the model depicted in Figure 4C, we specu-
late that this holoenzyme is binding to an as yet uniden-
tified AKAP that positions PKA close to its targets
(e.g., Cdc25b phosphatase and the recently identified
Wee1B kinase [22]), maintaining the inactive state of
Cdc25b and the active state of Wee1B by phosphoryla-
tion. In support of this, we find that GV-stage oocytes
injected with the PKA anchoring disruptor HT31 initiate
maturation even when the oocytes are maintained in
IBMX to keep cAMP and PKA activity high. Our exper-
iments with analogs demonstrate greater synergistic
inhibition of GVBD with RII analogs compared with RI
analogs, suggesting that the type II kinase is more
closely linked to the arrest of maturation in wild-type
oocytes.
When cAMP levels in the oocyte decline, PKA activity
declines and no longer maintains meiotic arrest. CDK1 is
dephosphorylated and becomes active, and maturation
is initiated. We suggest that activation of CDK1 sets in
motion the relocalization of RIIa-PKA to the mitochon-
dria, which occurs prior to GVBD. The molecular mech-
anisms that regulate this relocalization are unknown but
may involve posttranslational modifications of either
RIIa or AKAP1 that increase their interaction with each
other. In the AKAP1 knockout, RIIa does not associate
with mitochondria, and this loss of RIIa localization pre-
vents the ‘‘meiotic switch’’ from being thrown irrevers-
ibly. AKAPs are therefore playing a dual role in oocyte
maturation: they are required to maintain the PKA-de-
pendent arrest of oocytes at meiosis I prophase prior
to the LH surge, and, after the initiation of maturation,
AKAP1 plays an alternative and equally important role
in sequestering PKA away from its targets in order for
oocyte maturation to proceed normally and irreversibly.
Jackson et al. [23] suggested a sequestration role for
Drosophila AKAP200 similar to that proposed here for
AKAP1 based on studies of egg chamber and actin-
enriched ring canal development.
The increase in IVF procedures in the human popula-
tion has focused attention on oocyte maturation as a de-
terminant of successful fertilization, and several reports
have documented oocyte maturation defects as a cause
of IVF failure [24, 25]. Our results demonstrate the impor-
tance of temporal and spatial control of PKA signaling
during mammalian oocyte maturation.Supplemental Data
Supplemental Data include four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://
www.current-biology.com/cgi/content/full/16/3/321/DC1/.
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